美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Lunai Bioworks

1.06

+0.03002.91%

盘前：1.04-0.0152-1.43%08:34 EST

成交量：60.97万

成交额：65.77万

市值：2,456.89万

市盈率：-0.10

高：1.19

开：1.03

低：0.9653

收：1.03

52周最高：21.00

52周最低：0.8100

股本：2,317.82万

流通股本：1,500.00万

量比：0.70

换手率：4.06%

股息：- -

股息率：- -

每股收益(TTM):-10.7843

每股收益(LYR):-10.7843

净资产收益率：-321.81%

总资产收益率：-13.53%

市净率：-1.15

市盈率(LYR):-0.10

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Lunai Bioworks

交易所：

NASDAQ

成立时间：

- -

员工人数：

29

公司地址：

2080 Century Park East,Suite 906,Los Angeles,California,United States

官网：

http://www.renovarogroup.com

邮编：

90067

电话：

传真：

- -

简介：

Lunai Bioworks Inc.于2011年1月18日在特拉华州注册成立，通过三家子公司运营：Renovaro Biosciences、Renovaro Cube和BioSymetrics。Renovaro Cube，包括GediCube Intl。Ltd.及其子公司，于2024年2月13日被收购，而BioSymetrics及其子公司于2025年4月8日被收购。Renovaro Biosciences是该公司的生物技术部门，研究重点是开发旨在加强免疫反应的同种异体细胞和基因疗法，旨在支持长期癌症缓解。继收购GediCube INTL.后，Lunai越来越强调分子诊断和肿瘤技术。该公司的发展领域包括针对胰腺癌、肝癌、三阴性乳腺癌、头颈癌等实体瘤的创新治疗性疫苗接种平台。它的方法利用工程化供体细胞和分子诊断技术，有可能提供“现成的”治疗方案，减少诊断和治疗之间的延迟。

董事

名称

职位

David Weinstein

Director and Chief Executive Officer

Douglas W. Calder

Director

James A. McNulty

Director

Mark A. Collins

Director

股东

名称

职位

David Weinstein

Director and Chief Executive Officer

Nathen Fuentes

Chief Financial Officer

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/LNAI/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LNAI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LNAI\",,,,,undefined,":{"symbol":"LNAI","market":"US","secType":"STK","nameCN":"Lunai Bioworks","latestPrice":1.06,"timestamp":1763154000000,"preClose":1.03,"halted":0,"volume":609653,"hourTrading":{"tag":"盘前","latestPrice":1.0448,"preClose":1.06,"latestTime":"08:34 EST","volume":1434,"amount":1478.7932844,"timestamp":1763386443546},"delay":0,"floatShares":15000000,"shares":23178200,"eps":-10.784282,"marketStatus":"盘前交易","change":0.03,"latestTime":"11-17 08:40:51 EST","open":1.03,"high":1.19,"low":0.96525,"amount":657681.2194788001,"amplitude":0.218204,"askPrice":1.19,"askSize":200,"bidPrice":1.03,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-10.784282,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1763389800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":1.06,"preHourTrading":{"tag":"盘前","latestPrice":1.0448,"preClose":1.06,"latestTime":"08:34 EST","volume":1434,"amount":1478.7932844,"timestamp":1763386443546},"postHourTrading":{"tag":"盘后","latestPrice":1.0375,"preClose":1.06,"latestTime":"19:23 EST","volume":21477,"amount":22362.3501,"timestamp":1763166225776},"volumeRatio":0.698004535847056,"impliedVol":1.4337,"impliedVolPercentile":0.2581},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LNAI\",,,,,undefined,":{"symbol":"LNAI","floatShares":15000000,"roa":"-13.53%","roe":"-321.81%","lyrEps":-10.784282,"volumeRatio":0.698004535847056,"shares":23178200,"dividePrice":0,"high":1.19,"amplitude":0.218204,"preClose":1.03,"low":0.96525,"week52Low":0.81,"pbRate":"-1.15","week52High":21,"institutionHeld":0,"latestPrice":1.06,"committee":0.666667,"eps":-10.784282,"divideRate":0,"volume":609653,"delay":0,"ttmEps":-10.784282,"open":1.03,"prevYearClose":8.355,"prevWeekClose":1.06,"prevMonthClose":0.87,"prevQuarterClose":1.42,"fiveDayClose":0.9331,"twentyDayClose":1.2,"sixtyDayClose":2.288},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LNAI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-09-30","symbol":"LNAI","defaultRemindTime":1759239000000,"type":"split","dateTimestamp":1759204800000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2025-09-29","symbol":"LNAI","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1759118400000,"reportTimeType":"","actualEps":-0.76},{"market":"US","date":"2025-05-15","symbol":"LNAI","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":0},{"market":"US","date":"2025-02-19","symbol":"LNAI","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1739941200000,"reportTimeType":"post","actualEps":-0.02},{"market":"US","date":"2024-11-14","symbol":"LNAI","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.03}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LNAI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LNAI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LNAI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LNAI","date":"2025-11-14","current":-0.098291,"percent":0.645161,"low":-0.167985,"twenty":-0.161474,"median":-0.143888,"eighty":-0.121701,"high":-0.108594,"avg":-0.142338,"sd":0.01915,"marketCap":23873497},"quantilePoints":[{"date":"2025-10-03","current":-0.160171,"twenty":-0.164877,"median":-0.163112,"eighty":-0.161348,"marketCap":28511703},{"date":"2025-10-10","current":-0.161474,"twenty":-0.165919,"median":-0.164078,"eighty":-0.161474,"marketCap":28743506},{"date":"2025-10-17","current":-0.158869,"twenty":-0.16512,"median":-0.161474,"eighty":-0.158869,"marketCap":28279901},{"date":"2025-10-24","current":-0.135429,"twenty":-0.16512,"median":-0.160171,"eighty":-0.152098,"marketCap":24107456},{"date":"2025-10-31","current":-0.122514,"twenty":-0.163557,"median":-0.158218,"eighty":-0.135687,"marketCap":21808324},{"date":"2025-11-07","current":-0.132813,"twenty":-0.161474,"median":-0.152344,"eighty":-0.130739,"marketCap":23641716},{"date":"2025-11-14","current":-0.134115,"twenty":-0.161474,"median":-0.143888,"eighty":-0.121701,"marketCap":23873497}],"updateTime":1763351078349},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":549849556,"employeeNum":29,"address":"2080 Century Park East,Suite 906,Los Angeles,California,United States","zipCode":"90067","officePhone":"305 918 1980"},"stockCompanyDetail":{"websiteUrl":"http://www.renovarogroup.com","stockEarnings":[{"period":"1week","weight":0.136},{"period":"1month","weight":-0.1452},{"period":"3month","weight":-0.5567},{"period":"6month","weight":-0.6708},{"period":"1year","weight":-0.8184},{"period":"ytd","weight":-0.8731}],"compareEarnings":[{"period":"1week","weight":0.0014},{"period":"1month","weight":0.0102},{"period":"3month","weight":0.0443},{"period":"6month","weight":0.1308},{"period":"1year","weight":0.1324},{"period":"ytd","weight":0.1465}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lunai Bioworks Inc.于2011年1月18日在特拉华州注册成立，通过三家子公司运营：Renovaro Biosciences、Renovaro Cube和BioSymetrics。Renovaro Cube，包括GediCube Intl。Ltd.及其子公司，于2024年2月13日被收购，而BioSymetrics及其子公司于2025年4月8日被收购。Renovaro Biosciences是该公司的生物技术部门，研究重点是开发旨在加强免疫反应的同种异体细胞和基因疗法，旨在支持长期癌症缓解。继收购GediCube INTL.后，Lunai越来越强调分子诊断和肿瘤技术。该公司的发展领域包括针对胰腺癌、肝癌、三阴性乳腺癌、头颈癌等实体瘤的创新治疗性疫苗接种平台。它的方法利用工程化供体细胞和分子诊断技术，有可能提供“现成的”治疗方案，减少诊断和治疗之间的延迟。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.03245},{"month":2,"riseRate":0.428571,"avgChangeRate":0.007158},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.077517},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.083247},{"month":5,"riseRate":0.5,"avgChangeRate":-0.0442},{"month":6,"riseRate":0.375,"avgChangeRate":-0.147122},{"month":7,"riseRate":0.625,"avgChangeRate":-0.018947},{"month":8,"riseRate":0.625,"avgChangeRate":0.533577},{"month":9,"riseRate":0.375,"avgChangeRate":-0.022213},{"month":10,"riseRate":0.5,"avgChangeRate":-0.035033},{"month":11,"riseRate":0.75,"avgChangeRate":0.125263},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.10167}],"exchange":"NASDAQ","name":"Lunai Bioworks","nameEN":"Lunai Bioworks"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"LNAI\",market:\"US\",,,undefined,":{"directors":[{"name":"David Weinstein","position":"Director and Chief Executive Officer"},{"name":"Douglas W. Calder","position":"Director"},{"name":"James A. McNulty","position":"Director"},{"name":"Mark A. Collins","position":"Director"}],"executives":[{"name":"David Weinstein","position":"Director and Chief Executive Officer"},{"name":"Nathen Fuentes","position":"Chief Financial Officer"}]}}}